Estimating precise worldwide market share for individual Active Pharmaceutical Ingredients (APIs) is
challenging due to the highly fragmented nature of the API market, the confidential nature of
company-specific sales data, and the constant evolution of pharmaceutical landscapes.
However, I can provide you with insights into the overall market size, growth trends, key players,
and regional dynamics for each of the APIs you've listed, which will give you a good understanding of
their market standing.
Here's a breakdown for each API:
1. Glimepiride
Market Overview: Glimepiride is an oral antidiabetic drug used to manage type 2 diabetes.
The market for Glimepiride API is experiencing significant growth driven by the rising
prevalence of diabetes globally, increased awareness, and advancements in treatment
options. The increasing development of generic forms also enhances its affordability and
accessibility.
Market Size & Growth:
o The global Glimepiride Dispersible Tablet Market size was estimated at USD 1.05
billion in 2023 and is expected to reach USD 2.15 billion by 2033, growing at a CAGR
of around 7.43% from 2023 to 2033.
o The Glimepiride API Market is expected to grow at a CAGR of 12.4% during the
forecast period (though another source indicates 5% between 2021-2026 for the API
market).
Key Market Players (API & Formulations): Aurobindo Pharma Ltd., Intas Pharmaceuticals
Ltd., Novartis AG, Zydus Cadila, Aventis Pharma Limited, Alkem Laboratories Ltd., Hetero
Drugs Ltd., Torrent Pharmaceuticals, Ltd., Biocon Limited, Sun Pharmaceuticals Ltd.,
Glenmark Pharmaceuticals Ltd., Cipla Limited, Mankind Pharma Ltd., Dr. Reddy's
Laboratories Ltd., SANOFI Active Ingredient Solutions, Dishman Carbogen Amcis.
Regional Dominance: North America is anticipated to hold the largest share of the
Glimepiride dispersible tablet market. For the API market, Europe is projected to maintain
dominance due to increasing diabetes prevalence and advanced healthcare infrastructure,
while Asia-Pacific is expected to witness the fastest growth (with China being a key player).
2. Acotiamide
Market Overview: Acotiamide is a prokinetic drug used to treat functional dyspepsia. The
market for Acotiamide is growing steadily due to the increasing incidence of gastrointestinal
disorders.
Market Size & Growth:
o The global 100 Mg Acotiamide Tablets market size was US$ 664 million in 2024 and
is forecast to reach US$ 914 million by 2031 with a CAGR of 3.7% during the
forecast period 2025-2031.
o The global Acotiamide Hydrochloride market size is predicted to grow from US$ 815
million in 2025 to US$ 1051 million in 2031, at a CAGR of 4.3% from 2025 to 2031.
Key Market Players: Sun Pharmaceutical Industries Ltd., Steris Healthcare, Arlak Biotech,
Logos Pharma, AKUMS, Care Formulation Labs, Cista Medicorp, Zeria Pharmaceutical,
RADICALS PHARMA, XEMEX PHARMACEUTICALS PRIVATE.
Regional Dominance: Asia Pacific currently holds a significant share, and Europe is predicted
to increase its share. North America is also a notable market.
3. Luliconazole
Market Overview: Luliconazole is a topical antifungal agent used to treat various fungal skin
infections like tinea pedis, tinea cruris, and tinea corporis. The market is witnessing
significant growth fueled by advancements in dermatological treatments and increased
consumer focus on skincare, driven by the high prevalence of fungal infections worldwide.
Market Size & Growth: The global Luliconazole Market reached a valuation of USD 218.9
million in 2024 and is anticipated to expand to USD 366.16 million by 2033, reflecting a
steady CAGR of 5.88% during the forecast period [2025-2033].
Key Market Players: Emcure Pharmaceuticals Ltd, Zydus, Bausch Health Companies Inc,
Brinton Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, Hainan Hailing, NIHON
NOHYAKU CO. LTD.
Regional Dominance: Asia-Pacific holds the largest share of the luliconazole market, driven
by higher population density, tropical climates, and growing healthcare infrastructure. North
America follows closely.
4. Levosulpiride
Market Overview: Levosulpiride is primarily used for its prokinetic and antipsychotic
properties, often in the treatment of gastrointestinal disorders and certain psychiatric
conditions.
Market Size & Growth: The global Levosulpiride Market is growing at a faster pace and is
estimated to grow significantly in the forecasted period (e.g., 2020-2027 in one report).
Key Market Players: Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical, New
Donghai Pharmaceutical.
Regional Dynamics: India, Costa Rica, and China are noted as top exporters of Levosulpiride
API. Pakistan, Afghanistan, and Vietnam are major importers.
5. Venfotiamine (Benfotiamine)
Market Overview: Venfotiamine (also known as Benfotiamine) is a synthetic derivative of
thiamine (Vitamin B1) that is more readily absorbed by the body. It's used in dietary
supplements and pharmaceuticals, particularly for conditions related to thiamine deficiency
and diabetic complications. The broader thiamine market is growing due to increased
awareness of vitamin benefits and preventative healthcare.
Market Size & Growth (Thiamine Market, which includes Benfotiamine):
o The global thiamine market size was valued at USD 170.98 million in 2021 and is
expected to reach USD 549.9 million by 2030, expanding at a CAGR of 13.9% from
2022 to 2030.
o Another report indicates the global Thiamine Market Size to grow from USD 1.3
Billion in 2023 to USD 2.2 Billion by 2033, at a CAGR of 5.40% during the forecast
period.
Key Market Players (Thiamine): DSM, Chemizo Enterprise, Xinfa Pharmaceutical Co., Ltd.,
Jiangxi Tianxin Pharmaceutical Co., Ltd., Nutricost, McCartan's Pharmacy, Jiangsu Jubang
Pharmaceutical Co., Ltd., HPC.
Regional Dominance: Asia Pacific dominated the thiamine market with a revenue share of
over 35.0% in 2021. North America is anticipated to dominate the Thiamine Market from
2023 to 2033.
6. Deflazacort
Market Overview: Deflazacort is a corticosteroid primarily prescribed for the treatment of
Duchenne muscular dystrophy (DMD), a rare genetic illness. It's also used for other
inflammatory and autoimmune conditions. The market is witnessing significant growth
driven by increasing awareness and diagnosis of DMD, alongside rising incidence rates of
autoimmune disorders.
Market Size & Growth:
o The Deflazacort Market is expected to grow at a CAGR of 12.3% during the forecast
period.
o The global market for Deflazacort was valued at approximately
200millionin2022∗∗andisprojectedtoexpandata∗∗CAGRofaround7∗Theestimatedm
arketsizeforDeflazacortTablets(specificallyforDMD)was∗∗US 67 million for the
three months ending September 2023.
Key Market Players: Sanofi, Novartis, Leti, Teva, Nidda Healthcare, Aurobindo Pharma,
Zydus Lifesciences.
Regional Dominance: North America holds a market share of approximately 40%, followed
by Europe at 30%. The Asia-Pacific (APAC) region is expected to witness rapid growth,
projecting a market share of 20%, with China anticipated to contribute around 10%.
Important Considerations for Market Share:
API vs. Formulations: The market share figures often refer to the finished dosage form (e.g.,
tablets) rather than solely the active pharmaceutical ingredient. The API market is a segment
within the broader pharmaceutical market.
Generic vs. Branded: Many of these APIs have both branded and generic versions, which
impacts market dynamics and pricing.
Confidentiality: Companies generally do not disclose precise market share percentages for
individual APIs. The provided data is often based on market research reports that use
estimations and projections.
Dynamic Market: The pharmaceutical market is constantly evolving due to new drug
approvals, patent expirations, technological advancements, and changing healthcare
policies.
Tentative Rates and Indian API Manufacturers
1. Glimepiride API
Tentative Domestic Rate (India): ₹30000- ₹62,000 per Kg
Tentative Export Rate (India): Likely similar to the higher end of the domestic
range, with additional costs for logistics, packaging, and certifications.
Indian Manufacturers:
o Niksan Pharmaceutical (Surat, Gujarat)
o Atharva Science (Surat)
o Vimara Enterprises (Surat)
o Avip Impex (Surat)
o Zesla Chemicals And Pharmaceuticals (Surat)
o Neutral Pharma (Surat)
o Angle Biopharma (Ahmedabad)
o Hindustan Chemicals & Pharmaceuticals (Mumbai)
o BULL Pharmachem (Mumbai)
o N R Life Care (Ahmedabad)
o Jigs Chemical Limited (Ahmedabad)
o Akshar Pharmaceutical (Vapi, Valsad)
o Swasti Pharmachem (Thane)
o U. K. Vet Chem (Mumbai)
o Triveni Chemicals (Vapi, Valsad)
o Surgicare Pharma (Surat)
o Taarakesh Tech Private Limited (New Delhi)
o Cadixo Chemicals LLP (Surat)
o Indus Trading Company (Vadodara)
o Premier Medical Agency (Nagpur)
o PNG Biotec (Thane)
o Bionique Pharma (Surat)
o Dayaram Pharma Chem (Ankleshwar, Gujarat)
o Swati Chemicals (Ahmedabad)
o BNM Organics Private Limited (Kolkata)
o Surya Industries (Aurangabad)
o Indoco Remedies Limited (Mumbai)
o Rhyme Organics And Chemicals Private Limited (Hyderabad)
o Smaart Pharmaceutticals (Jalgaon)
o Matrica Laboratories (Hyderabad)
o Karunesh Remedies (Bharuch)
2. Acotiamide API
Tentative Domestic Rate (India): ₹12,000/- per Kg (ranges widely depending on
purity, grade, and supplier)
Tentative Export Rate (India): Varies, but likely within a similar broad range,
subject to specific market demand and quality requirements.
Indian Manufacturers:
o Newedge Overseas (Ahmedabad)
o Orbiton Pharma (Surat)
o Anant Pharmaceuticals Pvt. Ltd. (Ambernath, Maharashtra)
o Metrochem API Private Limited (Telangana)
o Hetero Drugs Limited (Telangana)
o Vijaya Pharma And Life Science (Tamil Nadu)
o A.J Chemicals (New Delhi)
o CLEARSYNTH LABS LTD. (Hyderabad)
o SynZeal Research Pvt Ltd (Gujarat)
3. Luliconazole API
Tentative Domestic Rate (India): ₹2500/-per Kg (some listings are lower like
₹2,100 - ₹2,500, which might be for specific purity or bulk quantities)
Tentative Export Rate (India): Around ₹25,00 per Kg, plus export costs.
Indian Manufacturers:
o N R Life Care (Ahmedabad)
o JK Chemicals (Vapi, Valsad)
o Angle Biopharma (Ahmedabad)
o Chemland Ind. (Valsad)
o Chemizo Enterprise (Ahmedabad)
o Akshar Pharmaceutical (Vapi, Valsad)
o Marq Chemicals (Surat)
o Atom Pharma (Surat)
o Cadixo Chemicals LLP (Surat)
o Aayushmaan Pharmachem (Haridwar)
o Orbiton Pharma (Surat)
o Acore Lifescience Private Limited (Vadodara)
o Cosmo Life Science (Thane)
o Niksan Pharmaceutical (Surat)
o Pellucid Pharma (Ahmedabad)
o Sarps Pharmaceutical Private Limited (Patna)
o Ichem (Surat)
o Gonane Pharma (India - confirmed by Pharmaoffer)
o Maithri Drugs (India - confirmed by Pharmaoffer)
4. Levosulpiride API
Tentative Domestic Rate (India): ₹8,500_ per Kg (some outliers at ₹195/Kg or
₹859/Kg, likely for very large volumes or specific grades/impurities)
Tentative Export Rate (India): Similar to the domestic range, with export additions.
Indian Manufacturers:
o Lyotex Lifesciences Private Limited (Navi Mumbai, Maharashtra)
o Cureworth Drugs & Intermediates Pvt. Ltd. (Ambernath, Maharashtra)
o Dayaram Pharma Chem (Ankleshwar, Gujarat)
o Shree Shreenivas Enterprise (Ahmedabad, Gujarat)
o N R Life Care (Ahmedabad)
o Hindustan Chemicals & Pharmaceuticals (Mumbai)
o Akhil Healthcare Private Limited (Vadodara)
o Angle Biopharma (Ahmedabad)
o Similis Pharma India LLP (Vapi, Valsad)
o Triveni Chemicals (Vapi, Valsad)
o Neutral Pharma (Surat)
o Vimara Enterprises (Surat)
o Premier Medical Agency (Nagpur)
o Sign Pharma Trade Services Pvt. Ltd. (Mumbai)
o Essentials Pharma (Rajkot)
o Intas Pharmaceuticals Ltd (mentioned as manufacturer of API on IndiaMART)
o Rajshi Farma Private Limited (New Delhi)
o Maurya Chemist & Druggist (Mumbai)
o Shree Rang Agency (Surat)
o Rag Healthcare (Surat)
5. Benfotiamine API (Venfotiamine)
Tentative Domestic Rate (India): ₹4000 - ₹5,500 per Kg (significant variation
depending on purity, grade, and supplier)
Tentative Export Rate (India): ₹3,500 - ₹4,100 per Kg, plus export costs.
Indian Manufacturers:
o Niksan Pharmaceutical (Surat)
o Varkana Dyechem (Surat)
o Ekikrta Industries Private Limited (Surat)
o Bionique Pharma (Surat)
o Jiyan Chemicals And Pharmaceuticals (Surat)
o Avience Chemicals And Pharmaceuticals (Surat)
o Neutral Pharma (Surat)
o Ambe NS Agro Products Private Limited (Ghaziabad)
o A M Nutratech Private Limited (New Delhi)
o Alenit Chemicals LLP (New Delhi)
o Kvell Life Sciences (New Delhi)
o Carewell Herbs (Faridabad)
o Vanity Vision (Faridabad)
o Cerata Pharmaceuticals (India)
6. Deflazacort API
Tentative Domestic Rate (India): ₹61,000 - ₹3,70,000 per Kg (highly variable,
reflecting different grades, purities, and potentially batch sizes)
Tentative Export Rate (India): ₹65,000 - ₹2,05,000 per Kg, plus export costs.
Indian Manufacturers:
o BULL Pharmachem (Mumbai)
o Hindustan Chemicals & Pharmaceuticals (Mumbai)
o N R Life Care (Ahmedabad)
o Angle Biopharma (Ahmedabad)
o Chemilux Pharma (Indore)
o Gathi Lifesciences (Hyderabad)
o Chemland Ind. (Valsad)
o JK Chemicals (Vapi, Valsad)
o Akshar Pharmaceutical (Vapi, Valsad)
o Deepen Drugs Pvt Ltd (Ahmedabad)
o Avience Chemicals And Pharmaceuticals (Surat)
o Neutral Pharma (Surat)
o Shreeji Pharma International (Vadodara)
o Beeman Pharmaceuticals (Mumbai)
o Cadixo Chemicals LLP (Surat)
o Ekikrta Industries Private Limited (Surat)
o Green Pharma (Hyderabad)
o Premier Medical Agency (Nagpur)
o Lyotex Lifesciences Private Limited (Navi Mumbai)
o Sky Remedies (India)
o Jovimag Lifesciences (India)
o VISIONARY EXPORTS (Indore)
o Raxuter Chemicals (India)
o JAI RADHE SALES (India)
o LIZA LIFE SCIENCES (India)
o AKIEZ HEALTHCARE (India)
o SLASH LIFEVISION (India)
o SPARK LIFESCIENCES (India)
o Talent Health Care (Ahmedabad)
o Veecube Healthcare Pvt. Ltd. (Panchkula)
o Venistro Biotech (Ambala Cantt)
o Qgensun Healthcare (Panchkula)
o Yassas Life Sciences (Ahmedabad)
o A.s. Life Sciences (India)
o Otex Lifesciences Pvt Ltd (India)
o Mednovation Healthcare (India)
o Neuracle Lifesciences (India)
o Jeffrey Remedies (India)
o Querit Healthcare (India)
o Care Formulation Labs Private Limited (India)
o Neoperix Pharma (India)
o Khushbu Medical Agency (India)
o Atom Pharma (Surat, Gujarat)